Lyka Labs Limited (BOM:500259)
71.42
+0.18 (0.25%)
At close: Feb 4, 2026
Lyka Labs Revenue
Lyka Labs had revenue of 307.28M INR in the quarter ending December 31, 2025, a decrease of -9.08%. This brings the company's revenue in the last twelve months to 1.30B, up 1.90% year-over-year. In the fiscal year ending March 31, 2025, Lyka Labs had annual revenue of 1.35B with 27.04% growth.
Revenue (ttm)
1.30B
Revenue Growth
+1.90%
P/S Ratio
1.96
Revenue / Employee
2.61M
Employees
499
Market Cap
2.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.35B | 287.16M | 27.04% |
| Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
| Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
| Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
| Mar 31, 2021 | 685.11M | 118.05M | 20.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZIM Laboratories | 3.66B |
| Amanta Healthcare | 2.76B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Sat Kartar Shopping | 1.63B |
| Gennex Laboratories | 1.49B |
| Trident Lifeline | 1.27B |
| Kerala Ayurveda | 1.26B |
| Oxygenta Pharmaceutical | 1.12B |
Lyka Labs News
- 6 months ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 10 months ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn